The FDA needs to change drug labels because there are concerns about the risks of oral contraceptives added to the mix. Progestin drugs that increase the synthesis of high-risk and Drospienone three times. Levonorgestrel Medication in pill form that are sold in multi-brand must have a label drug information to study if a dangerous drug that can cause blood clots to be in the medical division and would require a warning label. Do not. Focus on the benefits and risks of oral contraceptives. The decision to use contraceptives BMJ said the contraceptive patch or ring contraceptives. Higher risk in the use of contraceptive pills. Not just remodeled thrombosis alone caused by oral contraceptives, a study recently found that birth control pills, injectable DMPA, with the risk of breast cancer in magazines women health survey found that users. DMPA number 1024 used a contraceptive injection for a period of two months or more are at risk of cancer increased to 2.2 times, but if you stop taking the drug for five years, the risk is reduced
on 15 April research. Cancer was found in the risk of breast cancer in postmenopausal women reduced. This should be clarified to understand. Aware of the benefits and risks associated with contraceptive methods. To give the public the best choice of contraception.
การแปล กรุณารอสักครู่..